Raymond James reiterated their outperform score on shares of Thermo Fisher Scientific (NYSE:TMO – Free Report) in a analysis be aware issued to traders on Monday,Benzinga studies. Raymond James presently has a $667.00 goal worth on the medical analysis firm’s inventory, up from their prior goal worth of $650.00.
A variety of different equities analysts additionally just lately weighed in on TMO. Bernstein Financial institution elevated their worth goal on shares of Thermo Fisher Scientific from $565.00 to $625.00 and gave the inventory a “market carry out” score in a analysis be aware on Tuesday, October twenty second. Barclays minimize their goal worth on Thermo Fisher Scientific from $620.00 to $610.00 and set an “equal weight” score on the inventory in a analysis report on Wednesday, October twenty third. Wells Fargo & Firm upped their worth goal on Thermo Fisher Scientific from $660.00 to $680.00 and gave the inventory an “chubby” score in a analysis be aware on Friday. Morgan Stanley boosted their goal worth on Thermo Fisher Scientific from $647.00 to $678.00 and gave the inventory an “chubby” score in a report on Friday. Lastly, Robert W. Baird minimize their worth goal on shares of Thermo Fisher Scientific from $632.00 to $622.00 and set an “outperform” score on the inventory in a report on Thursday, October twenty fourth. 4 analysis analysts have rated the inventory with a maintain score and nineteen have given a purchase score to the inventory. Based on knowledge from MarketBeat.com, Thermo Fisher Scientific presently has a consensus score of “Reasonable Purchase” and a median worth goal of $658.00.
Get Our Newest Evaluation on Thermo Fisher Scientific
Thermo Fisher Scientific Worth Efficiency
TMO inventory opened at $593.38 on Monday. The corporate has a debt-to-equity ratio of 0.59, a fast ratio of 1.29 and a present ratio of 1.66. The inventory’s 50 day shifting common worth is $541.37 and its 200 day shifting common worth is $571.18. The agency has a market cap of $226.97 billion, a P/E ratio of 35.90, a PEG ratio of 4.06 and a beta of 0.77. Thermo Fisher Scientific has a 1 12 months low of $493.30 and a 1 12 months excessive of $627.88.
Thermo Fisher Scientific (NYSE:TMO – Get Free Report) final launched its earnings outcomes on Thursday, January thirtieth. The medical analysis firm reported $6.10 EPS for the quarter, topping the consensus estimate of $5.94 by $0.16. Thermo Fisher Scientific had a internet margin of 14.78% and a return on fairness of 17.51%. On common, sell-side analysts count on that Thermo Fisher Scientific will put up 23.29 earnings per share for the present fiscal 12 months.
Thermo Fisher Scientific Declares Dividend
The corporate additionally just lately disclosed a quarterly dividend, which was paid on Wednesday, January fifteenth. Traders of file on Friday, December thirteenth have been paid a dividend of $0.39 per share. This represents a $1.56 annualized dividend and a yield of 0.26%. The ex-dividend date was Friday, December thirteenth. Thermo Fisher Scientific’s dividend payout ratio (DPR) is presently 9.44%.
Thermo Fisher Scientific declared that its Board of Administrators has initiated a share buyback program on Friday, November fifteenth that permits the corporate to repurchase $4.00 billion in excellent shares. This repurchase authorization permits the medical analysis firm to purchase as much as 2% of its shares by means of open market purchases. Shares repurchase applications are normally an indication that the corporate’s management believes its inventory is undervalued.
Insider Exercise
In associated information, CEO Marc N. Casper bought 10,000 shares of the inventory in a transaction that occurred on Wednesday, November sixth. The inventory was bought at a median worth of $558.12, for a complete worth of $5,581,200.00. Following the completion of the transaction, the chief govt officer now instantly owns 33,608 shares of the corporate’s inventory, valued at $18,757,296.96. This represents a 22.93 % lower of their place. The sale was disclosed in a submitting with the SEC, which is obtainable by means of the SEC web site. Over the past ninety days, insiders bought 29,000 shares of firm inventory valued at $15,859,540. 0.34% of the inventory is presently owned by insiders.
Institutional Inflows and Outflows
Institutional traders and hedge funds have just lately modified their holdings of the enterprise. Legacy Funding Options LLC purchased a brand new stake in shares of Thermo Fisher Scientific throughout the third quarter value about $26,000. Peterson Monetary Group Inc. acquired a brand new place in shares of Thermo Fisher Scientific within the third quarter value roughly $27,000. Barrett & Firm Inc. acquired a brand new place in shares of Thermo Fisher Scientific within the 4th quarter valued at $28,000. Missouri Belief & Funding Co acquired a brand new stake in Thermo Fisher Scientific throughout the 4th quarter valued at $29,000. Lastly, Endeavor Personal Wealth Inc. bought a brand new place in shares of Thermo Fisher Scientific throughout the 4th quarter valued at $30,000. Institutional traders personal 89.23% of the corporate’s inventory.
Thermo Fisher Scientific Firm Profile
(Get Free Report)
Thermo Fisher Scientific Inc offers life sciences options, analytical devices, specialty diagnostics, and laboratory merchandise and biopharma providers within the North America, Europe, Asia-Pacific, and internationally. The corporate’s Life Sciences Options phase provides reagents, devices, and consumables for organic and medical analysis, discovery, and manufacturing of medication and vaccines, in addition to analysis of infections and ailments; and options embrace biosciences, genetic sciences, and bio manufacturing to pharmaceutical, biotechnology, agricultural, scientific, healthcare, educational, and authorities markets.
Featured Tales
Obtain Information & Scores for Thermo Fisher Scientific Every day – Enter your e-mail handle beneath to obtain a concise day by day abstract of the newest information and analysts’ rankings for Thermo Fisher Scientific and associated corporations with MarketBeat.com’s FREE day by day e-mail e-newsletter.
